Evidence map›Paper›PMID 18258688›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2008

Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells.

Abhi K Rao, Yvonne S Ziegler, Ian X McLeod, John R Yates, Ann M Nardulli

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mitochondria inter-organelle relationships in cancer protein aggregation.Frontiers in cell and developmental biology · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Abhi K RaoDepartment of Cellular and Development Biology, University of Illinois at Urbana, Urbana, Illinois 61801, USA.
Yvonne S Ziegler
Ian X McLeod
John R Yates
Ann M Nardulli
Scripps Research Institute · USUniversity of Illinois Urbana-Champaign · USUrbana University · US

Funding

ZDS2P REGULATES SWE1P-DEPENDENT POLARIZED CELL GROWTH IN S CEREVISIAEP41RR011823 · NCRR · UNIVERSITY OF WASHINGTON · PI DAVIS, TRACY · 1996 to 2011
$24.7M
INTERACTION OF THE ESTROGEN RECEPTOR WITH DNAR01DK053884 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI NARDULLI, ANN · 1999 to 2014
$4.0M
Interaction of the Estrogen Receptor with DNAR56DK053884 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NARDULLI, ANN · 2008 to 2008
$269k
NCRR NIH HHS P41 RR011823NCRR NIH HHS P41 RR11823-10NIDDK NIH HHS R01 DK053884NIDDK NIH HHS R01 DK53884NIDDK NIH HHS R56 DK053884
6 · The paper itself

Abstract

The effects of estrogen on gene expression in mammary cells are mediated by interaction of the estrogen receptor (ER) with estrogen response elements in target DNA. Whereas the ER is the primary initiator of transcription, the recruitment of coregulatory proteins to the DNA-bound receptor influences estrogen responsiveness. To better understand how estrogen alters gene expression, we identified proteins associated with the DNA-bound ERalpha. Surprisingly, the antioxidant enzyme Cu/Zn superoxide dismutase (SOD1), which is known primarily as a scavenger of superoxide, was associated with the DNA-bound receptor. We have now demonstrated that SOD1 interacts with ERalpha from MCF-7 cell nuclear extracts and with purified ERalpha and that SOD1 enhances binding of ERalpha to estrogen response element-containing DNA. Although SOD1 decreases transcription of an estrogen-responsive reporter plasmid in transiently transfected U2 osteosarcoma cells, RNA interference assays demonstrate that SOD1 is required for effective estrogen responsiveness of the endogenous pS2, progesterone receptor, cyclin D1, and Cathepsin D genes in MCF-7 breast cancer cells. Furthermore, ERalpha and SOD1 are associated with regions of the pS2 and progesterone receptor genes involved in conferring estrogen-responsive gene expression. Interestingly, when MCF-7 cells are exposed to 17beta-estradiol and superoxide generated by addition of potassium superoxide (KO2) to the cell medium, SOD1 levels are increased and tyrosine nitration, which is an indicator of oxidative stress-induced protein damage, is significantly diminished. Our studies have identified a new role for SOD1 in regulating estrogen-responsive gene expression and suggest that the 17beta-estradiol- and KO2-induced increase in SOD1 may play a role in the survival of breast cancer cells and the progression of mammary tumors.

Indexed as

Blotting, WesternBreast NeoplasmsCell Line, TumorChromatin ImmunoprecipitationElectrophoretic Mobility Shift AssayEstrogen Receptor alphaEstrogensFluorescent Antibody TechniqueHumansOxidative StressProtein BindingRNA InterferenceRNA, Small InterferingSuperoxide DismutaseSuperoxidesTranscription, GeneticEstrogen Receptor alphaEstrogenspotassium superoxideRNA, Small InterferingSuperoxide DismutaseSuperoxides

Identifiers

PMID18258688
PMCPMC2366184
OpenAlexW2043354782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.